Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108LYoshiko Urata, Yoichi Nakanishi, Hiroshige Yoshioka et al.|Journal of Clinical Oncology|2016Cited by 160
Multicenter, placebo‐controlled, double‐blind, randomized study of fosnetupitant in combination with palonosetron for the prevention of chemotherapy‐induced nausea and vomiting in patients receiving highly emetogenic chemotherapyShunichi Sugawara, Tomohide Tamura, Naoki Inui et al.|Cancer|2019Cited by 16